RU92004433A - AROMATIC AMINOSPIRAL DERIVATIVES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION - Google Patents

AROMATIC AMINOSPIRAL DERIVATIVES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION

Info

Publication number
RU92004433A
RU92004433A RU92004433/04A RU92004433A RU92004433A RU 92004433 A RU92004433 A RU 92004433A RU 92004433/04 A RU92004433/04 A RU 92004433/04A RU 92004433 A RU92004433 A RU 92004433A RU 92004433 A RU92004433 A RU 92004433A
Authority
RU
Russia
Prior art keywords
aminospiral
aromatic
derivatives
production
pharmaceutical composition
Prior art date
Application number
RU92004433/04A
Other languages
Russian (ru)
Other versions
RU2095344C1 (en
Inventor
Фудзита Такаси
Есиока Такао
Хорикоси Хироеси
Есиока Синдзи
Original Assignee
Санкио Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санкио Компани Лимитед filed Critical Санкио Компани Лимитед
Publication of RU92004433A publication Critical patent/RU92004433A/en
Application granted granted Critical
Publication of RU2095344C1 publication Critical patent/RU2095344C1/en

Links

Claims (1)

Предложены соединения формулы
Figure 00000001

где R0 - водородный атом, метил или гидроксиметил; R1 - замещенный алкил; каждый из R2 и R3 - атом водорода или галогена, гидрокси, алкокси-, карбоксигруппа, алкоксикарбонил, алкил, нитрогруппа, галоидалкил или замещенный алкил; X - атом кислорода или серы; Ar - возможно замещенный фенил или нафтил; их фармацевтически приемлемые соли, обладающие различными ценными фармацевтическими активностями, включая антидиабетическую активность и активность против ожирения. Кроме того, они пригодны для лечения или профилактики гиперлицемии и гипергликемии, а благодаря ингибированию действия альдозоредуктазы они также могут быть эффективными при лечении и профилактике осложнений диабетов.The proposed compounds of the formula
Figure 00000001

where R 0 is a hydrogen atom, methyl or hydroxymethyl; R 1 is substituted alkyl; each of R 2 and R 3 is a hydrogen or halogen atom, a hydroxy, alkoxy, carboxy group, alkoxycarbonyl, alkyl, nitro, haloalkyl or substituted alkyl; X is an oxygen or sulfur atom; Ar - possibly substituted phenyl or naphthyl; their pharmaceutically acceptable salts with various valuable pharmaceutical activities, including anti-diabetic and anti-obesity activities. In addition, they are suitable for treating or preventing hyperlicemia and hyperglycemia, and by inhibiting the action of aldose reductase, they can also be effective in treating and preventing complications of diabetes.
RU92004433/04A 1991-11-20 1992-11-19 1-amino-2-substituted phenylethanol derivatives and method of preparing thereof (variants) RU2095344C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30458191 1991-11-20
JP3-304581 1991-11-20

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU94036004/04A Division RU2081113C1 (en) 1991-11-20 1994-09-30 Thiazoliden-2,4-dione derivative, process for preparation thereof, thiazolidin-2,4-dione derivative as intermediate product when preparing aromatic aminoalcohol derivatives

Publications (2)

Publication Number Publication Date
RU92004433A true RU92004433A (en) 1996-04-27
RU2095344C1 RU2095344C1 (en) 1997-11-10

Family

ID=17934718

Family Applications (2)

Application Number Title Priority Date Filing Date
RU92004433/04A RU2095344C1 (en) 1991-11-20 1992-11-19 1-amino-2-substituted phenylethanol derivatives and method of preparing thereof (variants)
RU94036004/04A RU2081113C1 (en) 1991-11-20 1994-09-30 Thiazoliden-2,4-dione derivative, process for preparation thereof, thiazolidin-2,4-dione derivative as intermediate product when preparing aromatic aminoalcohol derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU94036004/04A RU2081113C1 (en) 1991-11-20 1994-09-30 Thiazoliden-2,4-dione derivative, process for preparation thereof, thiazolidin-2,4-dione derivative as intermediate product when preparing aromatic aminoalcohol derivatives

Country Status (23)

Country Link
US (3) US5977374A (en)
EP (1) EP0543662B1 (en)
JP (2) JP2654323B2 (en)
KR (1) KR0149679B1 (en)
CN (3) CN1033750C (en)
AT (1) ATE143002T1 (en)
AU (2) AU655689B2 (en)
CA (1) CA2083323A1 (en)
CZ (2) CZ280820B6 (en)
DE (1) DE69213892T2 (en)
DK (1) DK0543662T3 (en)
ES (1) ES2094308T3 (en)
FI (1) FI925255A (en)
GR (1) GR3021245T3 (en)
HK (1) HK218496A (en)
HU (1) HUT66816A (en)
IL (3) IL103825A (en)
MX (1) MX9206740A (en)
NO (1) NO179246C (en)
NZ (1) NZ245188A (en)
RU (2) RU2095344C1 (en)
TW (2) TW290543B (en)
ZA (1) ZA928960B (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587377A3 (en) * 1992-09-10 1994-09-21 Lilly Co Eli Thiazolidinone derivatives as hypoglycemic agents and for treating alzheimer's disease
GB9313574D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Medicaments
NO303782B1 (en) * 1994-03-23 1998-08-31 Sankyo Co Thiazolidine and oxazolidine derivatives and pharmaceutical preparations containing them, as well as their use in the manufacture of medicaments
NO305987B1 (en) * 1994-04-11 1999-08-30 Sankyo Co Heterocyclic compounds with antidiabetic activity, their use and pharmaceutical preparations containing these
WO1995033724A1 (en) * 1994-06-09 1995-12-14 Glaxo Group Limited Phenethanolamine derivatives and their use as atypical beta-adrenoceptor agonists
GB9525177D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
GB9525121D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
EP0783888A1 (en) 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
ATE231136T1 (en) * 1996-04-09 2003-02-15 Reddys Lab Ltd Dr THIAZOLIDINEDIONE DERIVATIVES HAVING ANTIDIABETIC, HYPOLIPIDEMIC AND ANTIHYPERTENSIVE PROPERTIES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
BR9711098B1 (en) 1996-07-01 2011-10-04 heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5990169A (en) * 1996-10-23 1999-11-23 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
GB9706707D0 (en) * 1997-04-02 1997-05-21 Glaxo Group Ltd Chemical compounds
JPH10338679A (en) * 1997-04-08 1998-12-22 Mitsubishi Rayon Co Ltd Production of thiazolidine derivative
GB9812709D0 (en) 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds
US6006419A (en) * 1998-09-01 1999-12-28 Millitech Corporation Synthetic resin transreflector and method of making same
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
GB9929297D0 (en) * 1999-12-11 2000-02-02 Glaxo Group Ltd Process
BR0109336A (en) * 2000-03-17 2003-06-24 Ajinomoto C0 Inc A medicament for the prevention, amelioration and / or treatment of a diabetic complication, a suitable or usable medicinal drug thereof, a method for preventing, ameliorating and / or treating a diabetic complication, and neuropathy, and uses of a sugar reducing agent. in postprandial blood and at least one agent selected from an antihypertensive agent, a vasodilating agent and an antihyperlipidemic agent
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
EP1300405B1 (en) * 2000-07-13 2007-04-18 Sankyo Company, Limited Amino alcohol derivatives
KR20030044013A (en) * 2000-10-20 2003-06-02 화이자 프로덕츠 인코포레이티드 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
US7709677B2 (en) 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
US20040267015A1 (en) * 2001-04-05 2004-12-30 Ajita Bhat Peptide deformylase inhibitors
TWI311133B (en) * 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
WO2003010157A1 (en) * 2001-07-23 2003-02-06 Dr. Reddy's Research Foundation Dioxane derivatives and a process for their preparation
JPWO2003016265A1 (en) 2001-08-17 2004-12-02 エーザイ株式会社 Cyclic compounds and PPAR agonists
AU2003209527A1 (en) 2002-02-27 2003-09-09 Pfizer Products Inc. Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
DOP2003000587A (en) * 2002-02-27 2003-08-30 Pfizer Prod Inc Ss3-ADRENERGIC RECEIVER AGONISTS
US6864268B2 (en) 2002-02-27 2005-03-08 Pfizer Inc. β3 adrenergic receptor agonists
BR0307996A (en) 2002-02-27 2004-12-07 Pfizer Prod Inc Processes and intermediates useful in the preparation of beta3-adrenergic agonist receptors
CA2551167C (en) 2003-12-23 2011-10-18 Astellas Pharma Inc. Aminoalcohol derivatives
EP1891971A4 (en) * 2005-01-31 2010-02-03 Ajinomoto Kk Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent
US8281846B2 (en) 2007-10-24 2012-10-09 Xiangrong Zhu Curtain
AU2008318293B2 (en) * 2007-11-01 2014-07-31 Howard Florey Institute Aryloxy amine compounds and their use as sodium channel modulators
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
US9522129B2 (en) 2010-08-03 2016-12-20 Velicept Therapeutics, Inc. Pharmaceutical Combination
AU2015358378A1 (en) 2014-12-03 2017-06-29 Velicept Therapeutics, Inc. Compositions and methods of using modified release solabegron for lower urinary tract symptoms
US9968531B2 (en) 2015-08-05 2018-05-15 Dupont Tate & Lyle Bio Products Company, Llc Deodorants containing 1,3-propanediol
PT3365321T (en) 2015-10-23 2024-01-12 B3Ar Therapeutics Inc Solabegron zwitterion and uses thereof
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
EP3778555A4 (en) * 2018-03-26 2022-03-02 Protech Co., Ltd. Novel compound and pharmaceutical composition for preventing or treating obesity or metabolic syndrome comprising same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US3976783A (en) * 1970-07-18 1976-08-24 Pfizer Inc. Method of stimulating the heart employing ureido substituted phenyl-alkanolamine, alkylamine and α-aminoalkyl ketone derivatives
GB1551260A (en) * 1976-02-09 1979-08-30 Allen & Hanburys Ltd Phenylethanolamine derivatives
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0023385B1 (en) * 1979-06-16 1982-12-15 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
DE3061205D1 (en) * 1979-06-16 1983-01-05 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
EP0025331B1 (en) * 1979-09-06 1983-03-02 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
DE3368258D1 (en) * 1982-07-16 1987-01-22 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
GB8620951D0 (en) * 1986-08-29 1986-10-08 Beecham Group Plc Compounds
US5194443A (en) * 1987-09-04 1993-03-16 Beecham Group P.L.C. Compounds
ATE186724T1 (en) * 1987-09-04 1999-12-15 Beecham Group Plc SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVES
GB8910374D0 (en) * 1989-05-05 1989-06-21 Ici Plc Chemical compounds
US5037842A (en) * 1990-06-05 1991-08-06 Pfizer Inc. Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
GB9111426D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
US5508296A (en) * 1991-07-30 1996-04-16 Yamanouchi Pharmaceutical Co., Ltd. Bisheterocyclic derivative or salt thereof
GB9313574D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Medicaments

Similar Documents

Publication Publication Date Title
RU92004433A (en) AROMATIC AMINOSPIRAL DERIVATIVES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION
NO179246C (en) Aromatic amino-alcohol derivatives and intermediates for their preparation
RU92004336A (en) WATER-SOLUBLE DERIVATIVES OF CAMPTOTECINE, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING ENZYM TOOPOISOMERS, INTERMEDIATE PRODUCTS
RU93048539A (en) OXAZOLIDINE DERIVATIVES, possessing anti-diabetic properties and action against obesity, their production and therapeutic use
JP2006501181A5 (en)
RU92016545A (en) HETEROCYCLIC COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION
KR870006016A (en) N-benzoyl urea compound, anti-tumor composition containing the same, and method for preparing the same
KR930702287A (en) New compound
PT69823A (en) 2- (2-ALKOXYETHYL) -2'-HYDROXY-6,7-BENZOMORPHANES OF THE ACIDIC ACID SALT THEREOF AND THE METHOD FOR THE PRODUCTION THEREOF
BR1100636A (en) Therapeutic agent for parkinson's disease, and, derived from xanthine
BR8202861A (en) COMPOUND COMPOSITION PHARMACEUTICAL PROCESS TO LOWER THE BLOOD PRESSURE OF HUMAN BEINGS PROCESS TO PREPARE A COMPOUND AND PROCESS TO PREPARE A PHARMACEUTICAL COMPOSITION
KR927003537A (en) 4,5-cycloalkano-3-benzeazin-7-ol derivatives and uses thereof
RU97103535A (en) IMIDAZOPIRIDINES AZOLIDINONES
DK0446921T3 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
KR960702456A (en) NP-Halobenzoylmethyl Derivatives of 4- (P-Fluorophenyl) -3-[(3,4- (methylenedioxy) phenoxy) methyl] piperidine ) -3-[[3,4- (METHYLENEDIOXY) PHENOXY] METHYL] PIPERIDINE)
ES500810A0 (en) AMINOALCOXIPIRAZOLES PREPARATION PROCEDURE
ATE76067T1 (en) DIHYDROPYRIDINE ETHERS, PROCESS FOR THEIR PRODUCTION AND USE.
RU93033697A (en) DERIVATIVES 2-AMINO-N - [[[4- (AMINOCARBONIL) PYRIMIDIN-2-IL] AMINO] ALKYL] PYRIMIDIN-4-CARBOXAMIDE, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION
EP0351696A3 (en) Allylaminoethylazoles
DE3770713D1 (en) 8-PHENYLTHIOTETRAHYDROQUINOLINE DERIVATIVES AND THEIR SALTS, THEIR PRODUCTION, USE AS MEDICINAL PRODUCTS AND COMPOSITIONS THEREOF.
DE69011174D1 (en) Catecholamine ester.
RU92016481A (en) NEW PYRMIDINE DERIVATIVES, METHOD OF THEIR PRODUCTION, NONAMOTCIDE COMPOSITION AND METHOD OF SUPRESSING NEMATOD
RU92016596A (en) DERIVATIVES OF PYRIMIDYL, METHOD OF THEIR PRODUCTION, NONAMOTCIDE COMPOSITION AND METHOD OF STRUGGLE AGAINST NEMATODES
RU92016468A (en) NEW PYRMIDINE DERIVATIVES, METHOD FOR THEIR PRODUCTION, NONAMOTCIDE COMPOSITION AND METHOD OF ADDITIONING NEMATOD
KR890011593A (en) Use of 2- (phenylamino) imidizoline- (2) for use in treating shock